Prosiectau (12568)
Cardiff University Schools involved in this Project
Targeting neuroinflammation in mTORC1 driven brain tumours (01.10.2019 - 31.05.2023)
- Tee, Andrew
Targeting NF-xB activation and proliferation signals in CLL (01.11.2013 - 31.07.2018)
- Pepper, Christopher
- Targeting novel anti-complement drugs to the brain for therapy of
dementia. (01.10.2021 - 31.12.2026)- Zelek, Wioleta
Targeting of interleukin-13 receptor (IL-13R) a2 expressing pancreatic cancer by a novel hybrid lytic peptide drug (01.10.2016 - 15.11.2018)
- Brancale, Andrea
Targeting Ref1/STAT3 to treat Tuberous Sclerosis (01.04.2018 - 09.02.2023)
- Tee, Andrew
Targeting the allosteric control of alarmone synthetases to tackle bacteria persistence (01.10.2017 - 15.01.2020)
- Jin, Yi
Targeting the CD8 coreceptor as a novel strategy for the treatment of type 1 diabetes (01.01.2013 - 31.12.2013)
Targeting the early endosome as a therapeutic strategy in neurodegenerative diseases (01.01.2024 - 14.04.2027)
- Connor-Robson, Natalie
Targeting the pathological pathways to Parkinson's (02.05.2018 - 01.08.2021)
- Webber, Caleb
Targeting the terminal pathway in complement - driven disease (30.06.2018 - 30.09.2018)
- Morgan, Paul